Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Frontiers in Tropical Diseases|February 23, 2023
Discovery of pyrazolopyrrolidinones as potent, broad-spectrum inhibitors of <i>Leishmania</i> infectionJohn A Kavouris, Laura-Isobel McCall, Miriam A Giardini, et al.International Journal for Parasitology. Drugs and Drug Resistance|July 21, 2020
Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivityCaio H Franco, David C Warhurst, Tapan Bhattacharyya, et al.The British Journal of Dermatology|May 19, 2018
Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelinesL Solman, M Glover, P E Beattie, et al.Bioinformatics (Oxford, England)|March 24, 2019
ORE identifies extreme expression effects enriched for rare variantsF Richter, G E Hoffman, K B Manheimer, et al.Biorxiv : the Preprint Server for Biology|January 12, 2022
Structure-based identification of naphthoquinones and derivatives as novel inhibitors of main protease Mpro and papain-like protease PLpro of SARS-CoV-2Lucianna H Santos, Thales Kronenberger, Renata G Almeida, et al.Journal of Chemical Information and Modeling|August 12, 2022
Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease M<sup>pro</sup> and Papain-like Protease PL<sup>pro</sup> of SARS-CoV-2Lucianna H Santos, Thales Kronenberger, Renata G Almeida, et al.European Journal of Medicinal Chemistry|December 9, 2024
Nanomolar activity of coumarin-3-thiosemicarbazones targeting Trypanosoma cruzi cruzain and the T. brucei cathepsin L-like proteaseJéssica Alves Nunes, Paulo Fernando da Silva Santos-Júnior, Midiane Correa Gomes, et al.Biorxiv : the Preprint Server for Biology|November 3, 2020
A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cellsDrake M Mellott, Chien-Te Tseng, Aleksandra Drelich, et al.ACS Chemical Biology|March 31, 2021
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey CellsDrake M Mellott, Chien-Te Tseng, Aleksandra Drelich, et al.ACS Infectious Diseases|February 12, 2025
Identification of Substituted 4-Aminocinnolines as Broad-Spectrum Antiparasitic AgentsAndrew Spaulding, Amrita Sharma, Miriam A Giardini, et al.Pageof 7